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Abstract: Prescription of implant treatments is very widespread at present, mainly due to the low rate
of annual loss and, to date, few studies have assessed their survival in the routine clinical practice of
dentistry. The purpose of this observational study was to evaluate the effectiveness of dental implants
with a calcium-phosphate surface in the daily practice of dental clinics. A multicenter, prospective,
non-interventional, observational study was performed, in which three experienced practitioners
(one maxillofacial and two oral surgeons) inserted implants using standard external and internal
hexagon connections in adult patients requiring ≥1 osseointegrated implants to replace missing
teeth. Follow-up was performed for 24 months after implant loading. Two hundred and twelve
subjects were included (51.5% men), with a mean age of 51.2 ± 11.90 years, in whom 544 implants
were inserted. 87.2% of the patients received 1–4 implants. The preferred connection system was
internal hexagon (73.5%). There were nine failures, with an interval survival rate (ISR) at 24 months
of 100% and a cumulative survival rate (CSR) of 98.3%. In conclusion, implants with a modified
calcium-phosphate surface are associated with a high rate of survival and may be considered a method
of choice in clinical practice.
Keywords: dental implants; modified calcium-phosphate surface; observational study; routine
clinical practice; survival rate; method of choice; osseointegrated implants
1. Introduction
The main reason for which treatment with endosseous dental implants is so widespread at present
is the low annual implant loss rate, as has been demonstrated by recent controlled trials, systematic
reviews and meta-analyses [1–7]. Nevertheless, implant treatment is not exempt from complications
and failures, both at short- (1.4 to 2.7%) and long-term (1.6 to 2.72% after more than nine years) [2,8,9].
According to the literature, these complications and failures are higher among smokers and patients
with an initial diagnosis of periodontitis [10–16].
To date, however, few reports have been published of studies in real-life conditions, in the
everyday clinical practice of dentistry [17–21].
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Generally speaking, it is known that the outcome of implant treatment basically depends on
the design of the implant, the position in which it is placed, the surgical technique, the conditions
of the patients and the type of prosthesis [22]. It has been estimated that at present dentists can
choose from more than 1300 different types of implants, made from different materials, in different
shapes, sizes, lengths and surface properties [23–25]. The Biomimetic Ocean implants (Avinent
Implant System, Barcelona, Spain), with a modified calcium-phosphate surface, have an innovative
geometry that adapts to the biological architecture of the bone promoting primary stability, preservation
of the bone and esthetics, and it has positive angle platform switching to facilitate soft tissue
adaptation. The implant is characterized by their biomimetic advanced surface, which is classified as
moderately rough, and has a surface topography that features macro-roughness, achieved through
a physical process, and microporosity obtained through a chemical process whereby calcium and
phosphorus are incorporated into the titanium oxide thus creating an osteoconductive surface that
enhances osseointegration [26].
To examine the survival of implants with a calcium-phosphate surface (Biomimetic Ocean implants),
including short (7 and 8.5 mm) and long implants (≥10 mm), a prospective, non-interventional, observational
study, with a 24-month follow-up, was designed in the routine clinical practice of dental clinics. The results
showed that implants with a modified calcium-phosphate surface were clinically osseointegrated, which
would be consistent with the high survival rates observed at 12-months and 24-months.
2. Results
A total of 212 subjects (51.5% men and 48.5% women) with 544 implants and a mean age of
51.2 ± 11.90 years were included. Demographic data, number of implants and oral health features of
the patients are shown in Table 1.
Table 1. Characteristics of the study population (n = 212).
Patients’ Characteristics n = 212 %
Age, mean (SD) 51.2 (11.9)
Gender, n (%) Men 109 51.5
Women 103 48.5
Implants per patient, median (IQR) 2.0 (2.0)
Smoking status, n (%) Smoker ≥ 10 cigarettes/day 20 9.4
Smoker < 10 cigarettes/day 20 9.4
Never smoked 172 81.1
Periodontal disease, n (%) No 148 69.8
Yes; controlled 64 30.2
Bruxism, n (%) No 136 64.2
Yes 76 35.8










SD: Standard deviation; IQR: Interquartile range.
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As shown in Figure 1, nine failures were recorded at different stages of the study: five during the
osseointegration period and four after prosthetic loading. A total of 11.6% of the implants could not be
evaluated because of different reasons (dropouts). The main reasons for which patients did not continue the
study were death, withdrawal from treatment due to economic reasons, or change of residence.J. Funct. Biom er. 2019, 10, x FOR PEER REVIEW 3 of 14 
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different stages of the study: five during the osseointegration period and four after prosthetic loading. 
The main oral risk factors for failure were smoking (18.8%), controlled periodontal treatment 
(30.2%) and bruxism (35.8%), without statistically significant differences between patients with or 
without failures. 
The majority of patients received between one and four implants (87.2%), while only three 
patients received 12 implants (Table 1). According to the distribution of the positioning, most of the 
implants were placed in the posterior region (Figure 2); 323 implants were placed in the maxilla 
(59.4%) and 221 in the mandible (40.6%). The most common placement site was 36 (9.9%) (lower left 
first molar), followed by 46 (8.3%) (lower right first molar). 
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Figure 1. Flow-chart and follow-up of the implants (n = 544) study in 212 patients during 24 months.
Number of failures that occurred at different stages of the study. Nine failures were recorded at different
stages of the study: five during the osseointegration period and four after prosthetic loading.
The main oral risk factors for failure were smoking (18.8%), controlled periodontal treatment
(30.2%) and bruxism (35.8%), without statistically significant differences between patients with or
without failures.
The majority of patients received between one and four implants (87.2%), while only three patients
received 12 implants (Table 1). According to the distribution of the positioning, most of the implants
were placed in the posterior region (Figure 2); 323 implants were placed in the maxilla (59.4%) and
221 in the mandible (40.6%). The most common placement site was 36 (9.9%) (lower left first molar),
followed by 46 (8.3%) (lower right first molar).
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Figure 2. Distribution of the implants according to positioning. The number of implants per tooth 
position is depicted in the maxilla (a) and in the mandible (b), according to the World Dental 
Federation notation. 
Internal connections were chosen most frequently (73.5% of cases). The preferred diameter was 
4.0 or 4.5 mm (68.7%) and the most frequently used length was 11.5 mm (42.8%) (Table 2). 
Table 2. Types of connection, diameters and lengths (n = 544). 
Characteristics of the Implants n % 
Connection, n (%) External hexagon 144 26.5 
 Internal hexagon 400 73.5 
Diameter, n (%) 3.5 mm 153 28.1 
 4.0 mm 185 34.0 
 4.5 mm 189 34.7 
 5.0 mm 17 3.1 
Length, n (%) 7.0 mm 1 0.2 
 8.5 mm 17 3.1 
 10.0 mm 155 28.5 
 11.5 mm 233 42.8 
 13.0 mm 138 25.4 
Bone density, n (%) Type I 44 8.1 
 Type II–III 430 79.0 
 Type IV 70 12.9 
Bone characteristics, n (%) Extraction site 36 6.6 
 Healed bone 378 69.5 
 Regenerated bone 130 23.9 
Surgical stages, n (%) 1 stage (healing abutment) 89 16.4 
 2 stages (cover screw) 455 83.6 
Type of loading, n (%) Immediate (<48 h) 32 5.9 
 Early (8–12 weeks) 33 6.0 
 Delayed (>12 weeks) 479 88.1 
Final position of the platform, n (%) Subcrestal 29 5.3 
 Crestal 510 93.8 
 Supracrestal 5 0.9 
Most of the implants (79%) were placed in bone density type II or III according to the Lekholm 
and Zarb classification system (Table 2). In the majority of cases, the bone had healed (69.5%) and in 
23.9% of cases, it was regenerated (including bone regeneration prior to surgery: sinus lifts, alveolar 
ridge preservation, etc., as well as regeneration during the surgery itself). 
Two-stage submerged healing was the technique selected in the majority of cases (83.6%), with 
time for osseointegration of more than three months (88.1%). Only 5.9% of the implants were loaded 
immediately. 
In 93.8% (n = 510) of cases the implant platform was placed at the crestal level, as indicated by 
the implant protocol that was used; 5.3% were left in the subcrestal position (n = 29) and only 0.9% in 
the supracrestal position (n = 5). 
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Federation notation.
Internal connections were chosen most frequently (73.5% of cases). The preferred diameter was
4.0 or 4.5 mm (68.7%) and the most frequently used length was 11.5 mm (42.8%) (Table 2).
Table 2. Types of connection, diameters and lengths (n = 544).
Characteristics of the Implants n %
Connection, n (%) External hexagon 144 26.5
Internal hexagon 400 73.5
Diameter, n (%) 3.5 m 153 28.1
4.0 m 185 34.0
4.5 m 189 34.7
5.0 m 17 3.1
Length, n (%) 7.0 mm 1 0.2
8.5 mm 17 3.1
10.0 mm 155 28.5
11.5 mm 233 42.8
13.0 mm 138 25.4
Bone density, n (%) Type I 44 8.1
Type II–III 430 79.0
Type IV 70 12.9
Bone characteristics, n (%) Extraction site 36 6.6
Healed bone 378 69.5
Regenerated bone 130 23.9
Surgical stages, n (%) 1 stage (healingabutment) 89 16.4
2 stages (cover screw) 455 83.6
Type of loading, n (%) Immediate (<48 h) 32 5.9
Early (8–12 weeks) 33 6.0
Delayed (>12 weeks) 479 88.1
Final position of the platform, n (%) Subcrestal 29 5.3
Crest l 510 93.8
Supracrestal 5 0.9
Most of th implants (79%) were placed in bone density type II or III according to the Lekholm
and Zarb classification syste (Table 2). In the majority of cases, the bone had healed (69.5%) and in
23.9% of cases, it was regenerated (including bone regeneration prior to surgery: sinus lifts, alveolar
ridge preservation, etc., as well as regeneration during the surgery itself).
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Two-stage submerged healing was the technique selected in the majority of cases (83.6%),
with time for osseointegration of more than three months (88.1%). Only 5.9% of the implants were
loaded immediately.
In 93.8% (n = 510) of cases the implant platform was placed at the crestal level, as indicated by the
implant protocol that was used; 5.3% were left in the subcrestal position (n = 29) and only 0.9% in the
supracrestal position (n = 5).
The type of prostheses that were used most frequently were bridges (54.2%) together with
individual crowns (29%), in both cases screwed directly to the implant, followed by cement-retained
restorations (6%) and attachment-retained overdentures (4.6%) (Table 3). In 58.8% of cases, the design
of the prosthesis was made using digital data acquisition and the material most often used for
manufacturing was milled CoCr (52.8%).
Table 3. Type of prosthetic restoration and material of the prosthesis (n = 504).
Prosthesis Characteristics n %
Material of the prosthesis, n (%) Cast Cobalt-Chromium 212 42.1
Milled Cobalt-Chromium 266 52.8
Milled Titanium 6 1.1
Others 20 4.0
Type of prosthetic restoration, n (%) Screw-retained crown 146 29.0
Screw-retained bridge 273 54.2
Cement-retained crown 6 1.2
Cement-retained bridge 24 4.8
Overdentures 23 4.6
Others 32 6.3
Design of the prosthesis, n (%) CAD-CAM 266 52.8
Conventional 238 47.2
During the 24 months of follow-up nine failures were documented, which represents a rate of
98.32% cumulative survival over time, as shown in the Kaplan Meier survival curve in Figure 3.
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Five implants failed during the period of osseointegration and four failed in the period after
prosthetic loading, as shown in Table 4. Three were lost because of postoperative infection, another
three due to fibro-osseous integration detected when the impression was made for the final prosthesis,
one as a result of peri-implantitis (inflammation and destruction of soft and hard tissues surrounding
dental implants) [27] and two were due to asymptomatic spontaneous avulsion of the implant (due to
fibro-integration).
It can be seen that the CSR of 462 implants at 12 months was 99.04% (95% confidence interval -CI-:
98.16–99.93) and at 24 months the CSR for 334 implants was 98.32% (95% CI: 96.94–99.70) (Table 5).
It was also found that no patient or technique-related risk factors affected the survival results,
demonstrating the predictability of the Avinent® system in any real everyday clinical situation (Table 6).
For this reason, a multivariate Cox regression analysis was not performed, since none of these factors
or variables affected implant survival (p > 0.05).
J. Funct. Biomater. 2019, 10, 5 7 of 14
Table 4. Characteristics of failures documented during the study.
Failure Position Months of Follow-Up Implant Bone Density Bone Characteristics Periodontal Disease Bruxism Smoking Age
1 23 3 3.5 × 13 IH Type II–III Regenerated bone Yes No Non smoker 76
2 31 13.70 3.5 × 13 IH Type II–III Regenerated bone No Yes Non smoker 43
3 47 4.27 4.0 × 10 IH Type II–III Healed bone No No Non smoker 62
4 31 5 3.5 × 11.5 IH Type II–III Alveolar after extraction No Yes Non smoker 45
5 26 0.23 4.0 × 10 IH Type II–III Healed bone No No Non smoker 60
6 26 3.30 4.5 × 10 IH Type II–III Regenerated bone Yes No Non smoker 64
7 36 18.63 4.5 × 10 IH Type II–III Regenerated bone Yes No Non smoker 57
8 46 6.53 4.0 × 10 IH Type II–III Healed bone No Yes Non smoker 35
9 37 4.20 4.0 × 11.5 IH Type II–III Healed bone Yes Yes Non smoker 44



















0–3 months 544 2 5 99.63 99.12 100.00 99.63 99.12 100.00
3–6 months 537 4 64 99.04 98.22 99.87 98.89 98.00 99.78
6–9 months 469 0 7 99.04 98.16 99.93 100.00 – –
9–12 months 462 0 12 99.04 98.16 99.93 100.00 – –
12–15 months 450 1 6 98.82 97.82 99.82 98.67 97.61 99.73
15–18 months 443 1 53 98.57 97.47 99.67 98.44 97.29 99.59
18–21 months 389 1 54 98.32 97.04 99.60 98.18 96.85 99.51
21–24 months 334 0 30 98.32 96.94 99.70 100.00 – –
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Table 6. Survival from start of follow-up to end of follow-up in terms of various risk factors (n = 544).
Patient Characteristics Cumulative Survival at24 Months (95% CI) Log-Rank p-Value
Age <65 years 98.14 (96.42–99.86) 0.413
≥65 years 99.02 (96.68–100.00)
Smoking Status Never smoked 97.86 (96.02–99.70) 0.226
Smoker < 10 cigarettes/day 100.00 (-)
Smoker ≥ 10 cigarettes/day 100.00 (-)
Periodontal disease No 98.49 (96.84–100.00) 0.339
Yes 97.93 (95.04–100.00)
Bruxism No 98.57 (96.99–100.00) 0.246
Yes, with/without bite splint 97.73 (94.60–100.00)
Position of the implant Mandible 97.35 (94.89–99.81) 0.136
Maxilla 99.06 (97.63–100.00)
Implant connection External hexagon 99.26 (96.86–100.00) 0.785
Internal hexagon 98.11 (96.44–99.78)
Bone density Type I 97.14 (90.73–100.00) 0.911
Type II-III 98.16 (96.45–99.87)
Type IV 100.00 (-)
Bone characteristics Extraction site 96.67 (88.81–100.00) 0.160
Healed bone 99.11 (97.87–100.00)
Regenerated bone 96.29 (91.70–100.00)
Surgical stages One stage (healingabutment) 95.72 (89.60–100.00) 0.268
Two stages (cover screw) 98.78 (97.45–100.00)
Type of loading Immediate (<48 h) 100.00 (-) 0.255
Early (8–12 weeks) 96.77 (93.34–100.00)
Delayed (>12 weeks) 98.37 (96.82–99.92)
Final position of the platform Subcrestal 100.00 (-) 0.699
Crestal 98.20 (96.66–99.74)
Supracrestal 100.00 (-)









Number of implants 1 93.26 (86.31–100.00) 0.157
>1 97.06 (93.92–100.00)




Although it may provide a standard design, materials and surface, any new system of dental
implants must undergo a scientific assessment to validate proper performance in conventional
clinical conditions.
The main objective of this multicenter, prospective, non-interventional, observational study
was to describe the 24-month survival rate of implants with a modified calcium-phosphate surface,
including short (7 and 8.5 mm) and long implants (≥10 mm), in daily clinical practice. The cohort
that was followed represents a real sample of patients who were treated according to the everyday
clinical practices of dental clinics. The assessment was also performed as part of the practitioners’
routine activity.
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A large proportion of published studies are constrained by numerous limitations, owing mainly
to the replication of the standard design of traditional clinical trials, for example, the inclusion and
exclusion criteria that are applied are usually very strict, as the condition of oral tissues must meet
certain standardized specifications or must have very well-defined defects [28]. These constraints
alone make it difficult to extrapolate the findings to the reality of daily dental practice or to the general
population. Among the many biases that can occur, follow-up bias is often encountered: patients who
participate in these studies are usually extremely controlled by the mere fact of having been selected.
By contrast, the selection of patients in observational studies is not as restrictive and treatment is
guided by the routine daily practice determined by the clinician or clinicians participating in the study.
In this study, the favorable results obtained should basically be attributed to the suitability of
the Ocean implant system and the skills of the practitioners. It is possible that in other health care
situations, with other less-skilled practitioners and/or with less clinical experience, the results would
not have been the same [29] and survival would have been lower.
In the 24 months of follow-up after implant loading, 9 failures were recorded. The 1.6% rate of
early failures—osseointegration period—is similar to that described in similar studies, both using
controlled and uncontrolled [9,30]. That is, 6 implants were lost in the first six months and only three
in the remaining 24 months.
The cumulative survival rate was 98.3%. The analysis of the variables that could be related to
implant loss did not identify any that would in itself explain treatment failure. Neither the implant
morphology nor the surgical technique or surface properties can explain the failed cases. We can
therefore say that the results obtained are independent of the variables described above.
The majority (33%) of patients only required a single implant and only 7.1% had six or more
implants, although the scientific literature indicates that the treatment with the most predictable
improvement of oral health-related quality of life (OHRQoL) is implant-supported or retained complete
dentures [31]. With regard to length and diameter, the preferred implants were 4.0 mm in diameter and
11.5 mm in length. Although the scientific literature validates their rate of survival [32], wider implants
were only placed in 3.1% of cases.
Both histologically and experimentally, it has been shown that the surface of implants with
a specific micro-topography design, as in the case of Biomimetic Ocean implants, can result in a higher
bone to implant contact with a much faster healing period than that necessary with older machined
implants [33]. The benefits of these surfaces must first be demonstrated in vitro and subsequently
in vivo, in order to have scientific and clinical validity. This is what has been done with the Biomimetic
Ocean implant by Avinent Implant System in this multicenter study. It was observed that the implants
with Biomimetic Advanced Surface were clinically osseointegrated in accordance with presently
required implant quality standards, which would be consistent with the high survival rate observed in
this study.
Osseointegration dental implants are available in different materials, body shapes, surface
properties and coatings. Numerous surface modifications including turned, blasted, acid-etched,
porous-sintered, oxidized, plasma-spayed surfaces, etc., or a combination of these procedures have
been developed and are currently used with the aim of enhancing clinical performance. It has been
shown that a prerequisite for a successful implant is a rapid osseointegration and a long-term stability.
In both cases, the implant surface is very important. A chemically-modified surface has beneficial
effects and significant improvements in the cell response and various surface modifications have been
described in the literature [26,34].
The Biomimetic Advanced Surface (BAS) treatment has been obtained by a combination of two
processes. First, a shot blasting procedure was carried out using aluminum oxide as a blast media.
Afterwards, the implants were anodized using an electrolyte solution rich in calcium and phosphate.
The BAS surface topography is characterized by the presence of macroroughness and microporosity in
the titanium oxide with a calcium and phosphorus deposit [26,34].
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Although we are conscious that this study was the first evaluation of this type of implants, and that
further studies with larger sample sizes and longer follow-up will be necessary, the results obtained in
this study allow us to conclude that implants with a modified calcium-phosphate surface are associated
with a high rate of survival and may be considered a method of choice in clinical practice.
4. Materials and Methods
4.1. Study Design
A multicenter, prospective, non-interventional, observational study was conducted to evaluate the
survival of Biomimetic Ocean implants (Avinent Implant System, S.L., Barcelona, Spain), which had
a patient inclusion period of three years (November 2011–November 2014) and a 24-month follow-up
after implant loading.
4.2. Ethics Statement
The study procedures were performed following to the ethical principles of the Declaration of
Helsinki and its subsequent revisions. All the subjects participating in the study gave their informed
written consent to participate in the study prior to inclusion and patient data were obtained from
the clinical records and entered in an archive with an anonymization procedure allowing patient
anonymity to be maintained.
4.3. Patients, Clinicians, and Implants
The patients included belonged to three private Spanish dental clinics (Barcelona, Girona,
and Madrid) and were over 18 years of age, with an indication for the insertion of one or more
implants to replace missing teeth. The presence of clinical conditions that contraindicated any type of
oral surgery was a criterion for exclusion.
After reading and signing the informed consent, all patients were assessed and treated for any oral
diseases that they presented. Likewise, the presence of systemic risk factors (metabolic diseases, taking
of prescription and nonprescription medication, alcohol and illicit drug use, radiation treatments,
oncological surgery, chronic illnesses and physical disabilities, among others) was noted.
Three experts—two oral surgeons and one oral and maxillofacial surgeon—who were familiar
with the implant system and certified in Spain to perform dental implant surgery and who have more
than 15 years of experience participated in the study.
Implants with standard external or internal hexagon connections (Biomimetic Ocean by Avinent
Implant System), having the same external geometry were used.
The implant bodies had diameters of 3.5, 4.0, 4.5, and 5.0 mm and lengths of 7.0, 8.5, 10.0, 11.5,
13.0, and up to 15.0 mm.
After the implants were integrated, a wide variety of prosthetic solutions by Avinent Implant
System were used for the rehabilitation.
No specific protocols were recommended either for implant placement or loading. However, in the
surgical phase, the position, type of implant to be placed and position of the platform were specified
along with other data. Loading protocols were classified according to the criteria defined by Cochran
et al. [35]: immediate restoration (placement within a maximum of 48 h of surgical implantation),
early loading (placement of the restoration between 48 h and three months after implant surgery)
and conventional loading (restoration is placed as a second step, after a healing period of three to six
months after the implant surgery).
The implants were loaded with single crowns that were cemented or screw-retained, splinted to
other implants as fixed partial or complete dentures or overdentures. All prosthetic components were
used according to standard guidelines and the manufacturer’s instructions for use. Implant loading
protocols were determined according to the criteria used at each of the participating clinics.
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During the first stage of treatment planning, the results of the radiographic examinations and
computerized tomography (CT, ProMax3DMid, Planmeca, Helsinki, Finland) scans (when performed),
as well as oral and clinical characteristics of the patients were assessed and surgery was scheduled.
Surgery was performed in the second stage, after which the following was recorded: patients
gender and age, implant position, dimensions, connection (internal hexagon (IH) or external hexagon
(EH)), bone density according to the Lekholm and Zarb classification system [36] (types I, II–III, IV),
characteristics of the bone (healed bone, post-extraction or regenerated bone), regeneration technique
(performed before or during surgery), final position of the platform (supracrestal, crestal, or subcrestal),
surgical technique (one-stage, when there was sufficient primary stability (>35 Ncm), or two-stage, in
which case the implant was left submerged for at least six months), and loading type (immediate, early
or delayed, based on the criteria described by Cochran et al.) [35].
Suture removal was performed 7–14 days after surgery. During the check-up visit prior to loading,
each implant was evaluated for various clinical and radiological aspects that could lead to a suspicion
of potential failure such as the possible presence of mobility, bleeding on probing, plaque index, and/or
bone loss.
After implant placement, the design of the prosthesis was done using computer-aided design
(CAD)-computer-aided manufactured (CAM) or conventional techniques; the type of restoration (single
or multiple, cemented or screwed, or direct to implant overdenture), material and manufacturing
process (milled titanium, milled, or cast cobalt-chromium, or other materials) were recorded.
A radiological evaluation after the implant placement and during follow-up (at one year and at
two years) was made in order to measure bone levels.
Follow-up was conducted for 24 months after loading through clinical visits, periapical and
panoramic radiographs with the corresponding analysis of implant function, during which the
complications involved in the process were noted. The follow-up schedule was divided into six
predefined periods: before surgery, after implant placement, after loading, six months later, one year
later and two years later.
4.4. Study Objectives and Variables
Implants were considered to have survived if they were at their site of placement and functioned
at follow-up control visits. Any implants that were lost spontaneously or extracted after placement
were recorded as failures.
Failures were classified as early when they occurred during the healing period and before loading,
or late, when they occurred after the prosthesis had already been attached to the implant.
Implants of patients who stopped coming to their follow-up visits were recorded as dropouts.
The primary objective of the study was to evaluate the effectiveness of the implant or its survival at
2 years, using the Kaplan-Meier method to calculate the interval survival rate (ISR) and the cumulative
survival rate (CSR), with the implant as the unit of analysis. ISR represents the proportion of implants
in a group that survive during a defined or specific time interval [37]. CSR represents the proportion
of items existing at the beginning of a time interval that survive until the end of the interval being
studied [38,39].
Bone density was assessed according to the Lekholm and Zarb classification system (types I,
II–III, IV) [36].
According to this classification, in Type I, the entire bone is composed of very thick cortical bone;
in Type II, thick layer of cortical bone surrounds a core of dense trabecular bone; in Type III, a thin
layer of cortical bone surrounds a core of trabecular bone of good strength; and in Type IV, there is
a very thin layer of cortical bone with low density trabecular bone of poor strength [40].
Assessment of implant stability, including assessment of regeneration, was evaluated using
standard techniques [41].
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4.5. Statistical Analysis
A descriptive analysis of measures of central tendency (mean, median) and dispersion
(interquartile range and standard deviation) was performed for quantitative variables according
to normality criteria (Kolmogorov-Smirnov test, p > 0.05), for both the participants in the study and the
implants, and qualitative variables were described by frequency and percentage. The Kaplan-Meier
test was used to assess implant survival and survival was compared over time with the log-rank test;
95% confidence intervals (95% CI) were presented. In every case, a p-value <0.05 was considered to be
statistically significant. The Statistical Package for the Social Sciences (SPSS) version 17.0 for Windows
(SPSS, IBM, Chicago, IL, USA) was used.
5. Conclusions
Implants with a modified calcium-phosphate surface are associated with a high rate of survival
and may be considered a method of choice in clinical practice.
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